4D Molecular Therapeutics Inc (FDMT)
25.70
+0.06
(+0.23%)
USD |
NASDAQ |
May 10, 16:00
25.68
-0.02
(-0.08%)
After-Hours: 20:00
4D Molecular Therapeutics Price to Book Value: 4.156 for May 10, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 10, 2024 | 4.156 |
| May 09, 2024 | 4.146 |
| May 08, 2024 | 4.258 |
| May 07, 2024 | 4.334 |
| May 06, 2024 | 4.327 |
| May 03, 2024 | 4.266 |
| May 02, 2024 | 4.266 |
| May 01, 2024 | 4.106 |
| April 30, 2024 | 3.870 |
| April 29, 2024 | 3.921 |
| April 26, 2024 | 3.760 |
| April 25, 2024 | 3.805 |
| April 24, 2024 | 3.921 |
| April 23, 2024 | 4.012 |
| April 22, 2024 | 4.267 |
| April 19, 2024 | 4.083 |
| April 18, 2024 | 4.007 |
| April 17, 2024 | 4.091 |
| April 16, 2024 | 4.326 |
| April 15, 2024 | 4.245 |
| April 12, 2024 | 4.261 |
| April 11, 2024 | 4.479 |
| April 10, 2024 | 4.355 |
| April 09, 2024 | 4.382 |
| April 08, 2024 | 4.649 |
| Date | Value |
|---|---|
| April 05, 2024 | 4.625 |
| April 04, 2024 | 4.470 |
| April 03, 2024 | 4.515 |
| April 02, 2024 | 4.525 |
| April 01, 2024 | 4.853 |
| March 28, 2024 | 5.152 |
| March 27, 2024 | 5.800 |
| March 26, 2024 | 5.506 |
| March 25, 2024 | 5.433 |
| March 22, 2024 | 5.433 |
| March 21, 2024 | 5.466 |
| March 20, 2024 | 5.417 |
| March 19, 2024 | 5.178 |
| March 18, 2024 | 5.018 |
| March 15, 2024 | 5.095 |
| March 14, 2024 | 4.749 |
| March 13, 2024 | 4.754 |
| March 12, 2024 | 4.614 |
| March 11, 2024 | 4.617 |
| March 08, 2024 | 4.782 |
| March 07, 2024 | 4.772 |
| March 06, 2024 | 4.570 |
| March 05, 2024 | 4.373 |
| March 04, 2024 | 4.648 |
| March 01, 2024 | 4.749 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.6197
Minimum
Jun 16 2022
17.88
Maximum
Dec 18 2020
2.861
Average
2.715
Median
Price to Book Value Benchmarks
| Ionis Pharmaceuticals Inc | 19.24 |
| NovaBay Pharmaceuticals Inc | 1.774 |
| Palatin Technologies Inc | -- |
| iBio Inc | 0.7009 |
| Theriva Biologics Inc | 0.2004 |
Price to Book Value Related Metrics
| PS Ratio | 48.43 |
| Price | 25.70 |
| Earnings Yield | -10.35% |
| Market Cap | 1.279B |